Alpha Mannosidosis Completed Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0037609 (Alpha Mannosidosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01043640Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersTreatment